Faculty Information |
|
Language | English |
The announcement title | Phase III trial of 24 weeks vs. 48 weeks capecitabine adjuvant chemotherapy for patients with stage III colon cancer: Final results of JFMC37-0801. |
Academic Society name | ESMO (European Society for Medial Oncology) 2016 |
Conference Type | International Society |
Announcement form | Poster presentation |
Presentation Type | General Lecture |
Lecture Type | Poster Display |
Publisher and common publisher | Yamaguchi Shigeaki Kunieda Katsuyuki, Sato Toshihiko, Naomoto Yoshio, Kobayashi Michiya, Ogata Yutaka, Furuhata Tomohisa, Takii Yasumasa, Kusunoki Masato, Maehara Yoshihiko, Koda Kenji, Okuno Kiyotaka, Ohno Masakazu, Mishima Hideyuki, Sadahiro Sotaro, Hamada Chikuma, Sakamoto Junichi, Saji Shigetoyo, Tomita Naohiro |
Date | 2016/10/10 |
Venue (city and name of the country) |
Copenhagen |